Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine
Different mechanisms mediate the toxicity of RNA. Genomic retroviral mRNA hijacks infected host cell factors to enable virus replication. The viral genomic RNA of the human immunodeficiency virus (HIV) encompasses nine genes encoding in less than 10 kb all proteins needed for replication in suscepti...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/14/2/138 |
_version_ | 1827652434693980160 |
---|---|
author | Yasemin van Heuvel Stefanie Schatz Jamila Franca Rosengarten Jörn Stitz |
author_facet | Yasemin van Heuvel Stefanie Schatz Jamila Franca Rosengarten Jörn Stitz |
author_sort | Yasemin van Heuvel |
collection | DOAJ |
description | Different mechanisms mediate the toxicity of RNA. Genomic retroviral mRNA hijacks infected host cell factors to enable virus replication. The viral genomic RNA of the human immunodeficiency virus (HIV) encompasses nine genes encoding in less than 10 kb all proteins needed for replication in susceptible host cells. To do so, the genomic RNA undergoes complex alternative splicing to facilitate the synthesis of the structural, accessory, and regulatory proteins. However, HIV strongly relies on the host cell machinery recruiting cellular factors to complete its replication cycle. Antiretroviral therapy (ART) targets different steps in the cycle, preventing disease progression to the acquired immunodeficiency syndrome (AIDS). The comprehension of the host immune system interaction with the virus has fostered the development of a variety of vaccine platforms. Despite encouraging provisional results in vaccine trials, no effective vaccine has been developed, yet. However, novel promising vaccine platforms are currently under investigation. |
first_indexed | 2024-03-09T20:55:25Z |
format | Article |
id | doaj.art-5c7d361651e4436ab2ca69930536b16d |
institution | Directory Open Access Journal |
issn | 2072-6651 |
language | English |
last_indexed | 2024-03-09T20:55:25Z |
publishDate | 2022-02-01 |
publisher | MDPI AG |
record_format | Article |
series | Toxins |
spelling | doaj.art-5c7d361651e4436ab2ca69930536b16d2023-11-23T22:21:59ZengMDPI AGToxins2072-66512022-02-0114213810.3390/toxins14020138Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a VaccineYasemin van Heuvel0Stefanie Schatz1Jamila Franca Rosengarten2Jörn Stitz3Research Group Pharmaceutical Biotechnology, Faculty of Applied Natural Sciences, TH Köln—University of Applied Sciences, Chempark Leverkusen, Kaiser-Wilhelm-Allee, 51368 Leverkusen, GermanyResearch Group Pharmaceutical Biotechnology, Faculty of Applied Natural Sciences, TH Köln—University of Applied Sciences, Chempark Leverkusen, Kaiser-Wilhelm-Allee, 51368 Leverkusen, GermanyResearch Group Pharmaceutical Biotechnology, Faculty of Applied Natural Sciences, TH Köln—University of Applied Sciences, Chempark Leverkusen, Kaiser-Wilhelm-Allee, 51368 Leverkusen, GermanyResearch Group Pharmaceutical Biotechnology, Faculty of Applied Natural Sciences, TH Köln—University of Applied Sciences, Chempark Leverkusen, Kaiser-Wilhelm-Allee, 51368 Leverkusen, GermanyDifferent mechanisms mediate the toxicity of RNA. Genomic retroviral mRNA hijacks infected host cell factors to enable virus replication. The viral genomic RNA of the human immunodeficiency virus (HIV) encompasses nine genes encoding in less than 10 kb all proteins needed for replication in susceptible host cells. To do so, the genomic RNA undergoes complex alternative splicing to facilitate the synthesis of the structural, accessory, and regulatory proteins. However, HIV strongly relies on the host cell machinery recruiting cellular factors to complete its replication cycle. Antiretroviral therapy (ART) targets different steps in the cycle, preventing disease progression to the acquired immunodeficiency syndrome (AIDS). The comprehension of the host immune system interaction with the virus has fostered the development of a variety of vaccine platforms. Despite encouraging provisional results in vaccine trials, no effective vaccine has been developed, yet. However, novel promising vaccine platforms are currently under investigation.https://www.mdpi.com/2072-6651/14/2/138retrovirusesHIVvirus replicationmRNA splicingantiretroviral therapy (ART)HIV vaccines |
spellingShingle | Yasemin van Heuvel Stefanie Schatz Jamila Franca Rosengarten Jörn Stitz Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine Toxins retroviruses HIV virus replication mRNA splicing antiretroviral therapy (ART) HIV vaccines |
title | Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine |
title_full | Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine |
title_fullStr | Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine |
title_full_unstemmed | Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine |
title_short | Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine |
title_sort | infectious rna human immunodeficiency virus hiv biology therapeutic intervention and the quest for a vaccine |
topic | retroviruses HIV virus replication mRNA splicing antiretroviral therapy (ART) HIV vaccines |
url | https://www.mdpi.com/2072-6651/14/2/138 |
work_keys_str_mv | AT yaseminvanheuvel infectiousrnahumanimmunodeficiencyvirushivbiologytherapeuticinterventionandthequestforavaccine AT stefanieschatz infectiousrnahumanimmunodeficiencyvirushivbiologytherapeuticinterventionandthequestforavaccine AT jamilafrancarosengarten infectiousrnahumanimmunodeficiencyvirushivbiologytherapeuticinterventionandthequestforavaccine AT jornstitz infectiousrnahumanimmunodeficiencyvirushivbiologytherapeuticinterventionandthequestforavaccine |